Regeneron Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報

MarketLineが発行した調査報告書(DATA904C14149)
◆英語タイトル:Regeneron Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C14149
◆発行会社(リサーチ会社):MarketLine
◆発行日:2019年3月
◆ページ数:61
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketLine社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Regeneron Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Regeneron Pharmaceuticals, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Regeneron Pharmaceuticals, Inc (Regeneron or ‘the company’) is a pharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious diseases. The company offer drugs for patients with cancer, eye diseases, cardiovascular and metabolic diseases, allergic and inflammatory diseases, infectious diseases, neuromuscular diseases, rare diseases and asthma. Its major drugs include Dupixent injection, Eylea injection, Arcalyst injection, Praluent injection, Libtayo Injection, Zaltrapinjection and Kevzara injection. Regeneron sells its products to various distributors and specialty pharmacies in the US. It operates manufacturing facilities in Limerick, Ireland and Rensselaer, New York, the US. The company is headquartered in Tarrytown, New York, the US.

Scope

- Detailed information on Regeneron Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Regeneron Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Regeneron Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Regeneron Pharmaceuticals, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Regeneron Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Regeneron Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Regeneron Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Regeneron Pharmaceuticals, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Regeneron Pharmaceuticals, Inc.: Company Overview
Regeneron Pharmaceuticals, Inc.: Overview and Key Facts
Regeneron Pharmaceuticals, Inc.: Overview
Regeneron Pharmaceuticals, Inc.: Key Facts
Regeneron Pharmaceuticals, Inc.: Key Employees
Regeneron Pharmaceuticals, Inc.: Key Employee Biographies
Regeneron Pharmaceuticals, Inc.: Major Products and Services
Regeneron Pharmaceuticals, Inc.: Company History
Regeneron Pharmaceuticals, Inc.: Management Statement
Regeneron Pharmaceuticals, Inc.: Locations and Subsidiaries
Regeneron Pharmaceuticals, Inc.: Key Competitors
Regeneron Pharmaceuticals, Inc.: Company Analysis
Regeneron Pharmaceuticals, Inc.: Business Description
Regeneron Pharmaceuticals, Inc.: SWOT Analysis
Regeneron Pharmaceuticals, Inc.: SWOT Overview
Regeneron Pharmaceuticals, Inc.: Strengths
Regeneron Pharmaceuticals, Inc.: Weaknesses
Regeneron Pharmaceuticals, Inc.: Opportunities
Regeneron Pharmaceuticals, Inc.: Threats
Regeneron Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Regeneron Pharmaceuticals, Inc.: Financial Deals Overview
Regeneron Pharmaceuticals, Inc.: Targets and Partners
Regeneron Pharmaceuticals, Inc.: Top Deals 2015 – 2019YTD*
Regeneron Pharmaceuticals, Inc.: Corporate Venturing
Regeneron Pharmaceuticals, Inc.: Partnership
Regeneron Pharmaceuticals, Inc.: Recent Developments
Regeneron Pharmaceuticals, Inc.: News and Events Summary
Regeneron Pharmaceuticals, Inc.: Business Expansion
Regeneron Pharmaceuticals, Inc.: Contracts
Regeneron Pharmaceuticals, Inc.: Corporate Governance
Regeneron Pharmaceuticals, Inc.: Market Developments
Regeneron Pharmaceuticals, Inc.: Regulatory and Legal Events
Regeneron Pharmaceuticals, Inc.: Research & Development
Regeneron Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Regeneron Pharmaceuticals, Inc.: Key Facts
Table 2: Regeneron Pharmaceuticals, Inc.: Key Employees
Table 3: Regeneron Pharmaceuticals, Inc.: Company History
Table 4: Regeneron Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 5: Regeneron Pharmaceuticals, Inc.: Key Competitors
Table 6: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Regeneron Pharmaceuticals, Inc.: Targets and Partners
Table 9: Regeneron Pharmaceuticals, Inc.: Top Deals 2015 - 2019YTD*
Table 10: Regeneron Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 11: Regeneron Pharmaceuticals, Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Table 12: Regeneron Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 13: Regeneron Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 14: Regeneron Pharmaceuticals, Inc.: News and Events Summary
Table 15: Regeneron Pharmaceuticals, Inc.: Business Expansion
Table 16: Regeneron Pharmaceuticals, Inc.: Contracts
Table 17: Regeneron Pharmaceuticals, Inc.: Corporate Governance
Table 18: Regeneron Pharmaceuticals, Inc.: Market Developments
Table 19: Regeneron Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 20: Regeneron Pharmaceuticals, Inc.: Research & Development
Table 21: Regeneron Pharmaceuticals, Inc.: Strategy and Operations

List of Figures
Figure 1: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Regeneron Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: Regeneron Pharmaceuticals, Inc.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 4: Regeneron Pharmaceuticals, Inc.: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 5: Regeneron Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 6: Regeneron Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2015 - YTD*2019)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Regeneron Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報(Regeneron Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆